Methodology for small animals targeted irradiations at conventional and ultra-high dose rates 65 MeV proton beam.

Dosimetry FLASH radiotherapy Monte Carlo simulation Preclinical studies Proton therapy

Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
20 Mar 2024
Historique:
received: 26 12 2023
revised: 20 02 2024
accepted: 11 03 2024
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 22 3 2024
Statut: aheadofprint

Résumé

As part of translational research projects, mice may be irradiated on radiobiology platforms such as the one at the ARRONAX cyclotron. Generally, these platforms do not feature an integrated imaging system. Moreover, in the context of ultra-high dose-rate radiotherapy (FLASH-RT), treatment planning should consider potential changes in the beam characteristics and internal movements in the animal. A patient-like set-up and methodology has been implemented to ensure target coverage during conformal irradiations of the brain, lungs and intestines. In addition, respiratory cycle amplitudes were quantified by fluoroscopic acquisitions on a mouse, to ensure organ coverage and to assess the impact of respiration during FLASH-RT using the 4D digital phantom MOBY. Furthermore, beam incidence direction was studied from mice µCBCT and Monte Carlo simulations. Finally,in vivodosimetry with dose-rate independent radiochromic films (OC-1) and their LET dependency were investigated. The immobilization system ensures that the animal is held in a safe and suitable position. The geometrical evaluation of organ coverage, after the addition of the margins around the organs, was satisfactory. Moreover, no measured differences were found between CONV and FLASH beams enabling a single model of the beamline for all planning studies. Finally, the LET-dependency of the OC-1 film was determined and experimentally verified with phantoms, as well as the feasibility of using these filmsin vivoto validate the targeting. The methodology developed ensures accurate and reproducible preclinical irradiations in CONV and FLASH-RT without in-room image guidance in terms of positioning, dose calculation andin vivodosimetry.

Identifiants

pubmed: 38518627
pii: S1120-1797(24)00126-1
doi: 10.1016/j.ejmp.2024.103332
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103332

Informations de copyright

Copyright © 2024 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Manon Evin (M)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France. Electronic address: manon.evin@subatech.in2p3.fr.

Charbel Koumeir (C)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; GIP ARRONAX, Saint-Herblain, France.

Arthur Bongrand (A)

GIP ARRONAX, Saint-Herblain, France; Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France.

Gregory Delpon (G)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France.

Ferid Haddad (F)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; GIP ARRONAX, Saint-Herblain, France.

Quentin Mouchard (Q)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France.

Vincent Potiron (V)

Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France; Nantes Université, CNRS, US2B, UMR 6286, F-44000 Nantes, France.

Gaëlle Saade (G)

Nantes Université, CNRS, US2B, UMR 6286, F-44000 Nantes, France.

Noël Servagent (N)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France.

Daphnée Villoing (D)

Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France.

Vincent Métivier (V)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France.

Sophie Chiavassa (S)

Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France.

Classifications MeSH